Effect of Natural and Synthetic Substances on Transformation of dUMP into dTMP

CSEF · 2003 Biochemistry/ Molecular Biology

Overview

Objectives/Goals Thymidylate synthase (TS) is the enzyme that catalyzes the transformation of deoxyuridine monophosphate (dUMP) into deoxythymidine monophosphate (dTMP) in cells. In cancer cells, TS is overexpressed. While usual drugs treat cancer by inhibiting TS, the New-Biotics' drug is a substrate of TS that produces toxic products upon TS activation. When the drug enters the cell it is transformed into bromovinyl deoxyuridine monophosphate (BVdUMP), a substrate for TS. Both dUMP and BVdUMP reactions require certain thiols, although other thiols inactivate TS, as researched in previous project. The natural reaction requires a cofactor, methylene-tetrahydrofolate (CH(2)-THF), but the BVdUMP reaction does not. The effect of different natural compounds on TS while it catalyses dUMP transformation to mimic its intracellular BVdUMP activation during chemotherapy was studied. Methods/Materials Different concentrations of CH(2)-THF were used while changing the concentrations of BVdUMP and dUMP, to find the effect of CH(2)-THF on BVdUMP inhibition of TS. Then irriversible inactivation of TS by BVdUMP was studied by preincubation the BVdUMP and enzyme and adding it to the reaction mixture. Results It was found that BVdUMP and dUMP are competitive substrates, so BVdUMP appears to act as an inhibitor for the natural reaction. It was also discovered that the higher the concentration of CH(2)-THF, the less the effect of the BVdUMP on the dUMP reaction. The irreversibility of TS inactivation by BVdUMP was also studied and it was discovered that for the first 30 minutes the inactivation is reversible and does not harm the enzyme, TS. The inactivation becomes irreversible over time. In the presense of CH(2)-THF the irreversible inactivation of TS by BVdUMP was less extreme than its absense. Conclusions/Discussion Since BVdUMP and dUMP are competitve substrates, they bind at the From this it was concluded that at higher CH(2)-THF concentration, BVdUMP is bound less tightly to the enzyme, meaning that they have mutually exclusive binding sites on the enzyme. CH(2)-THF also acts as a protector against irreversible inactivation of TS by BVdUMP.

Summary statement

New Biotics' drug, an alternative substrate of TS that competes with the natural substrate, is affected by CH(2)-THF and irreversibly inactivates TS only at long incubation times.

Help received

Used lab equipment at New Biotics, Inc. under the supervision of Dr. Maria Sergeeva.

Competition history

  • CSEF 2003 Biochemistry/ Molecular Biology · Entry S0418

Resources

Related projects

Closest projects by meaning, across every fair and year in the corpus.

Browse more like this

Source: California Science & Engineering Fair public projects

Save projects to your library

Sign in with Google to keep track of projects you find interesting, organized into folders. An account also raises your daily allowance for “Has this been done?”, and lets you create a key for the MCP server with a much higher limit than anonymous use. Browsing stays public.

Continue with Google